Cart
sales@molnova.com
Compound W
CAS No. 173550-33-9
Compound W( —— )
Catalog No. M23782 CAS No. 173550-33-9
The compound is an inhibitor of γ-secretase. It also causes a decrease in the released levels of Aβ42 and notch-1 Aβ-like peptide 25 (Nβ25).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 39 | In Stock |
|
| 50MG | 61 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCompound W
-
NoteResearch use only, not for human use.
-
Brief DescriptionThe compound is an inhibitor of γ-secretase. It also causes a decrease in the released levels of Aβ42 and notch-1 Aβ-like peptide 25 (Nβ25).
-
DescriptionThe compound is an inhibitor of γ-secretase. It also causes a decrease in the released levels of Aβ42 and notch-1 Aβ-like peptide 25 (Nβ25).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayNeuroscience
-
TargetGamma-secretase
-
Recptorγ secretase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number173550-33-9
-
Formula Weight396.31
-
Molecular FormulaC19H12N2O8
-
Purity>98% (HPLC)
-
SolubilityDMSO:<39.63mg/mL;1.1eq. NaOH:<19.81mg/mL
-
SMILES[O-][N+](c(cc1)ccc1Oc1cc(C(O)=O)cc(Oc(cc2)ccc2[N+]([O-])=O)c1)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Monomethyl auristati...
Monomethyl auristatin E (MMAE), an antimitotic agent, inhibits cell division by blocking the polymerization of tubulin and also has inhibition of antibody-drug conjugates (ADCs) activity.
-
CB-103
CB-103 is a orally active inhibitor of notch signaling pathway, with anti-tumor activity. CB-103 has shown the ability to block NOTCH signaling in human T cell acute lymphoblastic leukemia cancer cell lines, and?exhibits anti-tumor efficacy in GSI resistant T-ALL cell lines.
-
Legumain inhibitor 1
Legumain inhibitor 1 is a highly potent and specific Legumain inhibitor with potential anticancer activity for cancer research.
